<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Patients with long-term <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> are at risk for developing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Archival formalin-fixed paraffin-embedded tissue from <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> patients who underwent a colectomy for high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0002038'>carcinoma</z:mp> was examined for changes in expression of plasminogen activator inhibitor-1 (PAI-1) as well as other mediators of <z:mp ids='MP_0001845'>inflammation</z:mp>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Epithelia from areas of colons that showed histologic evidence of <z:mp ids='MP_0002038'>carcinoma</z:mp>, high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and epithelia that were not dysplastic or malignant but did contain evidence of prior <z:mp ids='MP_0001845'>inflammation</z:mp> (quiescent <z:hpo ids='HP_0002583'>colitis</z:hpo>) was microdissected using laser capture microscopy </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="2" ids="33699">mRNA</z:chebi> was extracted from the microdissected tissue and PCR array analysis was performed </plain></SENT>
<SENT sid="4" pm="."><plain>To extend our findings, PAI-1 protein levels were determined using immunohistochemistry </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of PAI-1 is increased 6-fold (p=0.02) when comparing the <z:mp ids='MP_0002038'>carcinoma</z:mp> group to the quiescent <z:hpo ids='HP_0002583'>colitis</z:hpo> group; increases were also observed in NFKB2, REL, SRC, and VEGFA </plain></SENT>
<SENT sid="6" pm="."><plain>The protein levels of PAI-1 are increased by 50% (p&lt;0.001) in high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and by 60% (p&lt;0.001) in <z:mp ids='MP_0002038'>carcinoma</z:mp> when compared to the quiescent <z:hpo ids='HP_0002583'>colitis</z:hpo> group </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The increase in PAI-1 in high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0002038'>carcinoma</z:mp> suggests a functional role for PAI-1 in <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> in <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>PAI-1 could also prove a useful diagnostic marker to identify patients at risk for <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and it may be a useful therapeutic target to treat <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>